Sign in
4/A

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-054738

Options or other derivatives

  • Director acquired 24,885 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Nishar Dipchand Director 2020-05-21 Grant or award · Stock Option (Right to Buy) +24,885 24,885 D: show line 1 in the form
Loading xslF345X03/doc4a.xml…